Palmitoylethanolamide

Palmitoylethanolamide

C₁₈H₃₇NO₂

544-31-0 Palmitoylethanolamide is an intermediate in organic synthesis and pharmaceutical that can be used in laboratory R&D processes and chemical R&D processes. PEA has been shown to have anti-inflammatory, anti-nociceptive injury, neuroprotective, and anticonvulsant properties. PEA has been exploring various pain states in people in different clinical trials for inflammation and pain syndromes. Conventional Shipping

Palmitoylethanolamide (Palmitoylethanolamide, abbreviated PEA), also known as palmitamide ethanol, is an endogenous fatty acid amide that belongs to the class of nuclear transcription factor agonists. PEA has been shown to bind to a receptor in the nucleus (nuclear receptor), has an impact on a variety of biological functions associated with chronic pain and inflammation, and is a natural anti-inflammatory agent [3]. The primary target of action of cetyamide is thought to be peroxisome proliferator-activated receptor α (PPAR-α).

Spot

< Previous< Back > Next >